重复低剂量裸盖菇素增强大鼠抗应激能力、减少强迫行为并强化丘脑室旁核皮层连接
该研究在大鼠中建立并验证了基于5-HT2A受体体内占据率推导的裸盖菇素重复低剂量(微剂量)方案。大鼠耐受良好,未出现快感缺失、焦虑或运动改变,前脉冲抑制无缺陷,5-HT2A受体未下调或脱敏。重复低剂量裸盖菇素使大鼠对多次皮下注射应激产生韧性,减少自我理毛频率,并增加丘脑室旁核5-HT7受体表达和突触密度。
要点
- 基于5-HT2A受体占据率建立大鼠裸盖菇素重复低剂量方案,耐受良好。
- 重复低剂量裸盖菇素增强抗应激韧性并减少自我理毛(强迫行为代理指标)。
- 机制涉及丘脑室旁核5-HT7受体表达和突触密度增加。
核心结论
- 重复低剂量裸盖菇素在大鼠中耐受良好,可增强抗应激韧性、减少强迫行为,并增加丘脑室旁核5-HT7受体表达和突触密度。
研究设计与样本
- 在大鼠中建立并验证基于脑内5-HT2A受体体内占据率推导的裸盖菇素重复低剂量方案。
主要发现
- 大鼠耐受重复低剂量裸盖菇素,未出现快感缺失、焦虑或运动改变,前脉冲抑制无缺陷,5-HT2A受体未下调或脱敏。
- 重复低剂量裸盖菇素使大鼠对多次皮下注射应激产生韧性,并减少自我理毛频率。
- 重复低剂量裸盖菇素增加丘脑室旁核5-HT7受体表达和突触密度。
临床怎么用
- 为后续重复低剂量裸盖菇素实验提供经过验证的方案。
- 为裸盖菇素微剂量作为治疗干预的 anecdotal 报告提供实证支持,并提示可能的生理机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psilocybin (a classic serotonergic psychedelic drug) has received appraisal for use in psychedelic-assisted therapy of several psychiatric disorders. A less explored topic concerns the use of repeated low doses of psychedelics, at a dose that is well below the psychedelic dose used in psychedelic-assisted therapy and often referred to as microdosing. Psilocybin microdose users frequently report increases in mental health, yet such reports are often highly biased and vulnerable to placebo effects. Here we establish and validate a psilocybin microdose-like regimen in rats with repeated low doses of psilocybin administration at a dose derived from occupancy at rat brain 5-HT2A receptors in vivo. The rats tolerated the repeated low doses of psilocybin well and did not manifest signs of anhedonia, anxiety, or altered locomotor activity. There were no deficits in pre-pulse inhibition of the startle reflex, nor did the treatment downregulate or desensitize the 5-HT2A receptors. However, the repeated low doses of psilocybin imparted resilience against the stress of multiple subcutaneous injections, and reduced the frequency of self-grooming, a proxy for human compulsive actions, while also increasing 5-HT7 receptor expression and synaptic density in the paraventricular nucleus of the thalamus. These results establish a well-validated regimen for further experiments probing the effects of repeated low doses of psilocybin. Results further substantiate anecdotal reports of the benefits of psilocybin microdosing as a therapeutic intervention, while pointing to a possible physiological mechanism.
引用
- Kiilerich KF, Lorenz J, Scharff MB, et al. Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats. Mol Psychiatry. 2023. PMID: 37783788. doi:10.1038/s41380-023-02280-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。